Generate Biomedicines Inc（GENB）價格預測

$15.790

+0.538 (+3.41%)收盤時

價格預測

1-Day Price Prediction

+0.24%

1-Week Prediction

+3.93%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

GENB 相似圖表分析預測

Alphio's GENB stock price prediction model matches the current Generate Biomedicines Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.32 (+0.24%). The 1-week path is $16.92 (+3.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Generate Biomedicines Inc 股票嗎？

Generate Biomedicines, Inc. is currently not a strong buy due to declining revenues and increasing net losses, despite a promising pipeline. The stock closed at $15.33, and the RSI is at 42.164, indicating a neutral momentum. The forward P/E is currently at 0, reflecting uncertainty in earnings growth. The main risk is the significant net loss of $67.3 million reported for Q2 2026, which raises concerns about liquidity and operational sustainability.